Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pulmonary hypertension and inflammation.

× No keyword cloud information.

43 in total

1. Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?

Authors: N F Voelkel; R M Tuder
Journal: J Clin Invest Date: 2000-09 Impact factor: 14.808

Review 2. PPARgamma as a potential therapeutic target in pulmonary hypertension.

Authors: Roy L Sutliff; Bum-Yong Kang; C Michael Hart
Journal: Ther Adv Respir Dis Date: 2010-06 Impact factor: 4.031

3. Vascular Dysfunction in Pneumocystis-Associated Pulmonary Hypertension Is Related to Endothelin Response and Adrenomedullin Concentration.

Authors: Dan W Siemsen; Erin Dobrinen; Soo Han; Kari Chiocchi; Nicole Meissner; Steve D Swain
Journal: Am J Pathol Date: 2015-12-11 Impact factor: 4.307

4. Soluble CD40 ligand levels in acute pulmonary embolism: a prospective, randomized, controlled study.

Authors: Zeynettin Kaya; Kurtulus Ozdemir; Mehmet Kayrak; Enes Elvin Gul; Gokhan Altunbas; Cetin Duman; Aysel Kiyici
Journal: Heart Vessels Date: 2011-04-14 Impact factor: 2.037

5. Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension.

Authors: Min Li; Suzette R Riddle; Maria G Frid; Karim C El Kasmi; Timothy A McKinsey; Ronald J Sokol; Derek Strassheim; Barbara Meyrick; Michael E Yeager; Amanda R Flockton; B Alexandre McKeon; Douglas D Lemon; Todd R Horn; Adil Anwar; Carlos Barajas; Kurt R Stenmark
Journal: J Immunol Date: 2011-08-03 Impact factor: 5.422

6. Contributions of pulmonary hypertension to HIV-related cardiac dysfunction.

Authors: Godsent C Isiguzo; Basil N Okeahialam; Solomon S Danbauchi; Augustine N Odili; Michael O Iroezindu; Ugoagwu Placid
Journal: Indian Heart J Date: 2013-09-02

7. Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice.

Authors: Yanli Song; Laura Coleman; Jianru Shi; Hideyuki Beppu; Kaori Sato; Kenneth Walsh; Joseph Loscalzo; Ying-Yi Zhang
Journal: Am J Physiol Heart Circ Physiol Date: 2008-06-13 Impact factor: 4.733

8. Protective effects of 10-nitro-oleic acid in a hypoxia-induced murine model of pulmonary hypertension.

Authors: Anna Klinke; Annika Möller; Michaela Pekarova; Thorben Ravekes; Kai Friedrichs; Matthias Berlin; Katrin M Scheu; Lukas Kubala; Hana Kolarova; Gabriela Ambrozova; Ralph T Schermuly; Steven R Woodcock; Bruce A Freeman; Stephan Rosenkranz; Stephan Baldus; Volker Rudolph; Tanja K Rudolph
Journal: Am J Respir Cell Mol Biol Date: 2014-07 Impact factor: 6.914

9. Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

Authors: Shiro Mizuno; Laszlo Farkas; Aysar Al Husseini; Daniela Farkas; Jose Gomez-Arroyo; Donatas Kraskauskas; Mark R Nicolls; Carlyne D Cool; Herman J Bogaard; Norbert F Voelkel
Journal: Am J Respir Cell Mol Biol Date: 2012-07-27 Impact factor: 6.914

10. Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent.

Authors: Brian Casserly; James R Klinger
Journal: Drug Des Devel Ther Date: 2009-12-29 Impact factor: 4.162